Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • ID: 3846533
  • Company Profile
  • 45 pages
  • Global Markets Direct
  • Actinium Pharmaceuticals Inc
1 of 4
Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

‘Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Actinium Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Actinium Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Actinium Pharmaceuticals, Inc.
- The report provides overview of Actinium Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Actinium Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Actinium Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Actinium Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Actinium Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Actinium Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Actinium Pharmaceuticals, Inc. Snapshot

Actinium Pharmaceuticals, Inc. Overview

Key Information

Key Facts

Actinium Pharmaceuticals, Inc. - Research and Development Overview

Key Therapeutic Areas

Actinium Pharmaceuticals, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Actinium Pharmaceuticals, Inc. - Pipeline Products Glance

Actinium Pharmaceuticals, Inc. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Actinium Pharmaceuticals, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Actinium Pharmaceuticals, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Actinium Pharmaceuticals, Inc. - Drug Profiles

Iomab-B

Product Description

Mechanism of Action

R&D Progress

Actimab-A

Product Description

Mechanism of Action

R&D Progress

BC-8Y90

Product Description

Mechanism of Action

R&D Progress

BC-8SA

Product Description

Mechanism of Action

R&D Progress

Actimab-B

Product Description

Mechanism of Action

R&D Progress

Actimab-Br

Product Description

Mechanism of Action

R&D Progress

Actimab-C

Product Description

Mechanism of Action

R&D Progress

Actimab-P

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugate for Hematological Tumor and Oncology

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugate for Oncology

Product Description

Mechanism of Action

R&D Progress

Actinium Pharmaceuticals, Inc. - Pipeline Analysis

Actinium Pharmaceuticals, Inc. - Pipeline Products by Target

Actinium Pharmaceuticals, Inc. - Pipeline Products by Route of Administration

Actinium Pharmaceuticals, Inc. - Pipeline Products by Molecule Type

Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action

Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates

Actinium Pharmaceuticals, Inc. - Dormant Projects

Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

Bismab-A

Actinium Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Actinium Pharmaceuticals, Inc., Key Information

Actinium Pharmaceuticals, Inc., Key Facts

Actinium Pharmaceuticals, Inc. - Pipeline by Indication, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Actinium Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Actinium Pharmaceuticals, Inc. - Phase III, 2016

Actinium Pharmaceuticals, Inc. - Phase II, 2016

Actinium Pharmaceuticals, Inc. - Phase I, 2016

Actinium Pharmaceuticals, Inc. - Preclinical, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Target, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016

Actinium Pharmaceuticals, Inc. - Dormant Developmental Projects,2016

Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 42List of Figures

Actinium Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Actinium Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Target, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Actinium Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll